Stay tuned for the 2021 edition!

Conference brings to Latin America the most recent discussions and promotes partnerships in Life Sciences, Healthcare and Biotechnology

News published on: October 8, 2019

BIO Latin America, held on September 3rd and 4th in São Paulo, gathered over 670 experts from 28 countries to discuss the trending topics for the sector and to showcase the innovation under development in the region.


SÃO PAULO, SEPTEMBER 2019 – The fifth edition of the BIO Latin America Conference provided participants the opportunity to establish professional ties and further develop the life sciences and biotechnology industry on the Latin American region. The event is part of BIO’s global portfolio of conferences hosted to drive innovation and stimulate the development of solutions for the sector on the most important and current themes.

Always built from the latest researches that are designing how the sector will unfold a few years from now, the 2019 BIO Latin America Conference focused on emerging biotechnologies and their potential to cure and transform healthcare, including personalized medicine, AI and machine learning, along with recent debates about biodiversity and the use of cannabis for healthcare innovation. 

On a stage that covered two simultaneous panel tracks, that made it possible for participants to follow as much as they could on the 16 thematic sessions held, the discussions also included topics such as international cooperation, corporate venture for biotech and healthcare, the presentation of innovative technologies and success stories on accelerating startups in Latin America.

Furthermore, 805 face-to-face meetings occurred during the event, scheduled through the BIO One-on-One Partnering™ system, fostering business development partnerships between the strategic players gathered at the event.

Mr. Eduardo Emrich, President and CEO at Biominas Brasil, and Mr. Justin Pine, Director of International Affairs at BIO, highlighted the opportunity that the event offers for cooperation between the various actors in the biotechnology and life sciences segment.



With a drive on promoting innovative technologies, the conference also featured the Innovation Arena, showcasing over 30 exhibitors, including 24 startups accelerated by Biominas. Participants included Janssen, Panarea Partners/Uruguay XXI, Brazilian Biodiversity Information System (SiBBr), Alnylam, Synova Health, Fiocruz,  Azidus, Dycem, Macrogen, and Procelys.

The Innovation Arena set the stage for two competitions: the Demoday of the BioStartup Academy 1st class and the Startup Stadium. At each competition, the 5 top startups of each program presented their pitch. The Brazilian startup “YLive” – dedicated to developing biotechnological solutions for animal nutrition, health and microbiota manipulation – was victorious at the Demoday of the BioStartup Academy 1st class; and the Puerto Rican startup “Isla Pharmaceuticals” – that is developing products for the prevention and treatment of mosquito borne illnesses (e.g.: Dengue) – was the winner of the Startup Stadium.



“Life Sciences in Brazil – The Impacts of Technology and Regulation”

Also within its programming, BIO Latin America 2019 witnessed the launch of a unique Report entitled “Life Sciences in Brazil – The Impacts of Technology and Regulation”, developed by Deloitte in partnership with Biominas and BIO, which aimed to identify among leaders of Brazilian life sciences companies, how the industry is positioning itself in Brazil in relation to technological developments affecting organizations, as well as in relation to a number of emerging regulatory issues. 

The survey found that the Brazilian Life Sciences industry is strongly engaged in innovation practices: more than 70% of companies claim to have an explicit innovation strategy. Among those who do not have, the largest portion claimed to be working in its implementation. Another finding from the Survey concluded that partnerships open to the public are only exercised by 12% of the participating companies that rely on an external collaboration model. To check-out the entire Report (available only in Portuguese), access here.



The BIO Latin America Conference is the result of a partnership between Biominas Brasil and the Biotechnology Innovation Organization (BIO). The 2019 edition brought together 676 attendees from the life sciences industry representing more than 353 companies and 28 different countries. 

The event welcomed high-level Brazilian government representatives, such as ANVISA, Apex-Brasil, BNDES, FINEP, INPI, Ministry of Science, Technology, Innovations & Communications, Ministry of Economy, and Ministry of Health, as well as from national industry associations, including ABIFINA, ABIMO, ABIQUIFI, ANAHP, ANPEI, ANPROTEC, and INTERFARMA. 

The Conference was also attended by several Latin American neighbors from the region’s main life sciences markets (Argentina, Chile, Colombia, Costa Rica, Mexico, Panama, Paraguay, Peru and Uruguay). Representatives from each of these countries had the opportunity to exchange best practices with other regions, presenting the reality of their markets in search of partners for their development and continuous growth. The event also attracted representatives from other countries, from regions such as North America, Europe and Asia.

BIO Latin America 2019 was supported by relevant private and public players, including Janssen as PLATINUM Sponsor; Novartis, Panarea Partners/Uruguay XXI, Pfizer and Brazilian Biodiversity Information System (SiBBr) as GOLD Sponsors; Amgen, Di Blasi Parente & Associados and Sanofi as SILVER Sponsors; Global Innovation Policy Center (GIPC), MSD, Phytobios and Rede Brasil-Biotec as BRONZE Sponsors; Alnylam, Biolab, Cells for Cells, Deloitte, Gilead, IFPMA, Kybora, FIEMG/BH Airport/Biotech Logística, Natura, Synova Health as CONFERENCE Sponsors; Fundação Oswaldo Cruz (Fiocruz) as an Institutional Supporter, and Nauweb as Official Digital Partner; besides several other media partners also strategic to the success of the event.

For more details on the BIO Latin America Conference, such as results, photos and download of presentations, please visit BIO and Biominas will soon announce the date and venue of the BIO Latin America 2020. Stay tuned!



Biotechnology Innovation Organization (BIO)

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States, and in more than 30 other countries. BIO members are involved in research and development of innovations in health, agriculture, industry and environmental biotechnology products. BIO also organizes the BIO International Convention, the largest meeting of the biotech industry in the world, as well as organizing other partnering and investment events of this industry around the globe. For more information, visit

Biominas Brasil

Biominas Brasil is a private institution, founded in 1990, whose mission is to create impact business on the life sciences sector. Biominas’ activities are based on 4 fundamental pillars: Academy (creation of courses and modules of education/training of human resources in life sciences); Think Tank (production of report/studies on the life sciences market in Brazil); Corporate (together with large and medium-sized companies, works to establish corporate innovation and relationship with startups); Innovation Builder (creation and development of promising startups). These pillars encompass a series of initiatives and services that consolidate Biominas as the most relevant institution working with innovation in life sciences in Brazil. Learn more at